IDEXX Laboratories (IDXX) Releases Quarterly Earnings Results

IDEXX Laboratories (IDXX) released its earnings data on Friday. The company reported $0.72 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.71 by $0.01. IDEXX Laboratories’s revenue was up 10.2% compared to the same quarter last year.

A number of research firms have also recently commented on IDXX. Analysts at Feltl & Co. raised their price target on shares of IDEXX Laboratories from $87.50 to $90.00 in a research note to investors on Monday, April 23rd. They now have a “hold” rating on the stock. On the ratings front, analysts at Leerink Swann upgraded shares of IDEXX Laboratories from a “market perform” rating to an “outperform” rating in a research note to investors on Monday, April 23rd. Finally, analysts at Bank of America (NYSE: BAC) raised their price target on shares of IDEXX Laboratories from $93.00 to $94.00 in a research note to investors on Friday, April 20th. They now have a “buy” rating on the stock.

IDEXX Laboratories (IDXX) traded down 1.63% on Monday, hitting $86.68. IDEXX Laboratories (IDXX) has a 1-year low of $63.83 and a 1-year high of $89.50. The company has a market cap of $4.771 billion and a price-to-earnings ratio of 30.58.

IDEXX Laboratories, Inc. (IDEXX) develops, manufactures and distributes products, and provides services primarily for the veterinary and the production animal, water testing and dairy markets.

Stay ahead of the market with Analyst Ratings Network's daily email update that provides a summary of analysts' upgrades, downgrades and new coverage. Click here to register now.

Posted by Web Inquirer Staff on 14 May 2012. Filed under Markets. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.